Your Body Has 3 Hearts – Here's How They Work

Cardiovascular disease remains the leading cause of mortality worldwide, accounting for an estimated 17.9 million deaths each year, according to the World Health Organization. These deaths represent approximately 32% of all global deaths, with over four out of five cardiovascular disease (CVD) fatalities resulting from heart attacks and strokes. Yet for all the clinical attention directed at the heart as a standalone organ, a foundational concept in cardiovascular physiology is routinely overlooked — the human body does not rely on a single pump to sustain circulation; It relies on three.(check the video)

This is not a metaphor. It is grounded in well-established haemodynamic science. Adequate blood circulation, particularly venous return from the lower extremities back to the cardiac chambers, depends on coordinated contributions from the myocardium, the skeletal muscle pump of the lower limb, and the endothelial and vascular tone of the peripheral blood vessel network. When any one of these three systems is compromised, the entire circulatory architecture begins to fail, often years before a patient receives a formal cardiac diagnosis.

Understanding how all three work and why all three must be protected, is not an exercise in academic anatomy. It is the clinical foundation of informed heart health.

The First Heart: The Myocardium

The cardiac muscle, approximately 300 grams of contractile tissue — executes an estimated 100,000 beats per day, propelling roughly 7,200 litres of blood through the systemic and pulmonary circulations every 24 hours. Its efficacy depends on patent coronary arteries, intact valve function, and a precise electrical conduction system.

When coronary artery disease (CAD) develops, atherosclerotic plaque progressively narrows the arterial lumen, reducing oxygen delivery to myocardial tissue. The clinical consequence: angina pectoris, dyspnoea, or myocardial infarction, reflects the point at which the heart's demand for oxygenated blood exceeds what diseased vessels can supply. Globally, CAD accounts for nearly half of all cardiovascular deaths, and prevalence continues to rise in populations with high rates of diabetes, hypertension, and metabolic syndrome.

The conventional treatment pathway — pharmacotherapy, percutaneous coronary intervention (angioplasty with stenting), or coronary artery bypass grafting (CABG) addresses the myocardium's blood supply problem through mechanical or surgical correction. These interventions remain critical in acute presentations. However, they do not restore the function of the two supporting pumps that work alongside the heart. And this omission has significant long-term consequences.

The Second Heart: The Calf Muscle Pump

The calf musculature, specifically the gastrocnemius and soleus complex; operates as what cardiovascular physiologists have long termed the "peripheral heart." During rhythmic contraction, the calf muscles compress the deep venous sinuses of the lower limb, generating intramuscular pressure differentials of approximately 140 mmHg and expelling venous blood centrally toward the right cardiac chambers.

One-way venous valves ensure unidirectional flow, preventing retrograde pooling. This mechanism is not merely supportive — it is essential. Research published by the Mayo Clinic's Gonda Vascular Laboratory (Halkar et al., Vascular Medicine, 2020), following 2,728 patients over more than a decade, demonstrated that impaired calf muscle pump function was an independent predictor of all-cause mortality, even after adjusting for established comorbidities.

Why Calf Pump Function Declines

Sedentary behaviour, prolonged sitting, peripheral arterial disease, and advancing age all progressively diminish calf pump efficiency. When venous return falters, cardiac preload diminishes, stroke volume decreases, and the myocardium is compelled to compensate, an unsustainable demand on an already-stressed organ. Clinically, patients with impaired lower limb circulation frequently present with ankle oedema, deep vein thrombosis risk, venous insufficiency, and fatigue that is mistakenly attributed solely to cardiac insufficiency.

In the context of heart disease management, neglecting the calf pump is a significant clinical oversight. Restoring and maintaining its function is integral to any comprehensive, non surgical heart treatment strategy.

The Third Heart: The Vascular System

The 100,000 kilometres of blood vessels that comprise the human circulatory system are not passive conduits. The arterial wall comprising the intima, media, and adventitia is a physiologically active structure. The endothelial lining of arteries and arterioles continuously modulates vascular tone through the release of vasoactive agents including nitric oxide (NO), prostacyclin, and endothelin-1.

This regulatory function, known as endothelium-dependent vasodilation, constitutes the body's own mechanism for distributing blood flow according to metabolic demand. In healthy vasculature, shear stress from blood flow stimulates the endothelium to produce nitric oxide, causing arteriolar relaxation and enhanced perfusion of downstream tissue. In pathological states, particularly those involving atherosclerosis, diabetes, and chronic hypertension; endothelial function is profoundly impaired.

Endothelial Dysfunction and Its Cardiac Consequences

Endothelial dysfunction precedes clinically detectable atherosclerosis by years, if not decades. When the vascular endothelium loses its capacity to produce adequate nitric oxide, the resultant vasoconstriction, platelet aggregation, and inflammatory infiltration accelerate plaque formation within the coronary arteries. The third heart, in effect, creates the conditions that compromise the first.

This systemic vascular deterioration also explains why isolated coronary interventions frequently provide incomplete relief. A stent may restore patency to one vessel, but it cannot address the endothelial dysfunction that persists throughout the peripheral circulation nor can it regenerate the collateral microvascular network that healthy vessels produce in response to ischaemic stress.

When Any One of the Three Fails

The three-pump model carries significant clinical implications. Symptoms of cardiovascular compromise — exertional chest pain, breathlessness, fatigue, and reduced exercise tolerance are not always purely myocardial in origin. They may reflect:

●      Inadequate venous return secondary to calf pump dysfunction

●      Peripheral vasoconstriction and impaired endothelial-mediated dilation

●      Microvascular insufficiency driven by systemic atherosclerosis

●      Reduced cardiac preload from lower limb venous stasis

Patients who undergo successful revascularisation, whether by angioplasty or bypass and continue to experience symptoms are often presenting with failure of the second or third pump. This is a well-recognised clinical pattern that warrants a more comprehensive approach to circulation management than revascularisation alone provides.

Shared Risk Factors Across All Three Systems

A critical insight in this framework is that the same modifiable risk factors that damage the myocardium also progressively impair the calf pump and the peripheral endothelium. These include:

●      Type 2 diabetes mellitus — impairs endothelial nitric oxide synthesis and promotes peripheral neuropathy, reducing calf muscle proprioception and pump activity

●      Systemic hypertension, accelerates endothelial injury, vascular remodelling, and left ventricular hypertrophy simultaneously

●      Dyslipidaemia, drives atherosclerotic progression in both coronary and peripheral vessels

●      Physical inactivity, the single most reversible factor affecting all three pumps; walking alone activates the calf pump, generates vascular shear stress, and improves endothelial function

●      Tobacco use directly toxic to the vascular endothelium across the entire circulatory tree

Managing All Three: A Systems Approach to Heart Health

Optimal cardiovascular management must address all three pumps in parallel. Pharmacological therapy — statins, antihypertensives, antiplatelet agents remains foundational. Structured physical activity, weight management, and glycaemic control support all three systems. However, for patients with established coronary artery disease, advanced symptoms, or post-interventional residual ischaemia, pharmacotherapy and lifestyle modification alone are frequently insufficient.

This is the context in which non-invasive cardiac therapy has emerged as a clinically meaningful adjunct. Enhanced External Counterpulsation — EECP therapy, acts directly on both the second and third pumps simultaneously. By applying sequential pneumatic compression to the lower limbs in synchrony with the cardiac cycle, EECP therapy for coronary artery disease augments venous return (replicating calf pump function), increases diastolic coronary perfusion pressure, and through sustained haemodynamic shear stress, stimulates endothelial nitric oxide production and promotes collateral angiogenesis.

For patients evaluating EECP vs bypass surgery, or those seeking heart blockage treatment without operation, EECP offers a structured, evidence-based, outpatient alternative. Clinical data from the MUST-EECP trial and the International EECP Patient Registry document reductions in angina frequency exceeding 60–70%, with benefits sustained for up to five years post-treatment. Is EECP therapy safe? Extensively validated as a non-invasive, FDA-approved treatment, EECP carries no anaesthetic risk, requires no hospitalisation, and is well-tolerated across a broad patient population, including elderly individuals and those with multiple comorbidities.

Heal Your Heart: Addressing the Complete Circulatory System

At Heal Your Heart a pioneer in EECP therapy in India since 2001 and a unit of Vaso-Meditech Private Limited, Chennai — the clinical philosophy reflects precisely this systems-level understanding. The EECP therapy heart programme at Heal Your Heart is designed to restore haemodynamic efficiency across the peripheral and coronary circulation, not merely to manage individual symptoms. Each patient undergoes a structured course of 35 sessions administered under expert cardiological supervision, with protocols aligned to internationally recognised guidelines.

For patients presenting with chronic stable angina, residual ischaemia post-revascularisation, or those seeking a viable alternative to repeat surgical intervention, the programme offers clinically backed, personalised care that addresses the root haemodynamic deficits, across all three hearts.

Conclusion

Heart disease is not a single-organ problem. The myocardium, the calf muscle pump, and the peripheral vascular endothelium together constitute the circulatory architecture that sustains life. Clinical evidence increasingly supports the view that effective cardiovascular care must account for all three systems; not as separate entities, but as an integrated network in which each component's dysfunction compounds the others'.

For patients and clinicians alike, this framework reframes the question from "what is wrong with the heart?" to "what is the state of the entire circulation?" a shift that opens the door to more complete, more durable, and more physiologically coherent treatment strategies.

The three hearts work in concert. Protecting all three is the only rational foundation for long-term cardiovascular health. Contact: 9003070065